|
ES2248822T3
(es)
|
1995-09-15 |
2006-03-16 |
Dale N. Gerding |
Procedimientos y composiciones para la prevencion y el tratamiento de enfermedades asociadas al clostridium difficile.
|
|
AUPQ899700A0
(en)
*
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US20090197249A1
(en)
|
2004-11-01 |
2009-08-06 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
AU2006219475B8
(en)
|
2005-03-03 |
2013-02-07 |
Meiji Co., Ltd. |
Immune function modulating agents
|
|
US9603876B2
(en)
|
2008-09-25 |
2017-03-28 |
New York University |
Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
|
|
GB0916335D0
(en)
*
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
ES2916399T3
(es)
*
|
2010-02-01 |
2022-06-30 |
Rebiotix Inc |
Bacterioterapia para la colitis por Clostridium difficile
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
KR20130098320A
(ko)
|
2010-08-04 |
2013-09-04 |
토마스 줄리어스 보로디 |
분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
|
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
EP2713726A2
(en)
|
2011-05-23 |
2014-04-09 |
Washington State University Research Foundation |
Use of photosynthetic pigment stabilizing agents to regulate ripening and quality in fruits and vegetables
|
|
CA2848757C
(en)
|
2011-09-14 |
2021-11-09 |
University Of Guelph |
Methods to culture human gastrointestinal microorganisms
|
|
CN104160014A
(zh)
|
2011-12-01 |
2014-11-19 |
国立大学法人东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
|
CN104780932A
(zh)
|
2012-02-29 |
2015-07-15 |
伊西康内外科公司 |
微生物区系的组合物及与其相关的方法
|
|
WO2013146319A1
(ja)
|
2012-03-30 |
2013-10-03 |
味の素株式会社 |
糖尿病誘起細菌
|
|
ES2792106T3
(es)
|
2012-05-18 |
2020-11-10 |
Genome Res Ltd |
Métodos y grupos
|
|
CN106620189B
(zh)
|
2012-06-06 |
2021-11-19 |
上海交通大学 |
改善肠道菌群结构的方法及应用
|
|
NZ709392A
(en)
|
2012-11-23 |
2016-10-28 |
Seres Therapeutics Inc |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
JP2016509003A
(ja)
|
2013-02-04 |
2016-03-24 |
セレス セラピューティクス インコーポレイテッド |
組成物および方法
|
|
WO2014153194A2
(en)
|
2013-03-14 |
2014-09-25 |
Seres Health, Inc. |
Methods for pathogen detection and enrichment from materials and compositions
|
|
BR112015023124A2
(pt)
*
|
2013-03-14 |
2017-07-18 |
Therabiome Llc |
liberação de organismos probióticos e/ou agentes terapêuticos almejada para o trato gastrintestinal
|
|
AU2014232370B2
(en)
|
2013-03-15 |
2018-11-01 |
Société des Produits Nestlé S.A. |
Network-based microbial compositions and methods
|
|
WO2014150094A1
(en)
|
2013-03-15 |
2014-09-25 |
University Of Florida Research Foundation, Inc. |
Butyrogenic bacteria as probiotics to treat clostridium difficile
|
|
EP3019181A4
(en)
|
2013-07-09 |
2016-09-21 |
Puretech Ventures Llc |
COMPOSITIONS WITH COMBINATIONS OF BIOACTIVE MOLECULARS DERIVED FROM MICROBOTS FOR TREATING DISEASES
|
|
AU2014331610B2
(en)
|
2013-10-03 |
2019-11-07 |
Trustees Of The University Of Pennsylvania |
Compositions comprising a defined microbiome and methods of use thereof
|
|
DK3074027T3
(da)
|
2013-11-25 |
2025-03-17 |
Nestle Sa |
Synergistiske bakteriesammensætninger og fremgangsmåder til fremstilling og anvendelse heraf
|
|
WO2015095241A2
(en)
|
2013-12-16 |
2015-06-25 |
Seres Health, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
JP6617935B2
(ja)
|
2014-04-10 |
2019-12-11 |
国立研究開発法人理化学研究所 |
Ｔｈ１７細胞の誘導のための組成物及び方法
|
|
EP3134509A4
(en)
|
2014-04-23 |
2017-09-13 |
Cornell University |
Modulation of fat storage in a subject by altering population levels of christensenellaceae in the gi tract
|
|
US20170087196A1
(en)
|
2014-05-19 |
2017-03-30 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for reducing clostridium difficile infection
|
|
EP4529950A3
(en)
|
2014-10-31 |
2025-08-20 |
Pendulum Therapeutics, Inc. |
Methods and compositions relating to microbial treatment
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
ES3010296T3
(en)
|
2014-11-25 |
2025-04-02 |
Memorial Sloan Kettering Cancer Center |
Intestinal microbiota and gvhd
|
|
KR102561989B1
(ko)
|
2015-05-14 |
2023-07-31 |
핀치 테라퓨틱스 홀딩스 엘엘씨 |
대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
|
|
WO2016185469A1
(en)
|
2015-05-21 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Bacterial populations for promoting health
|
|
US20180153944A1
(en)
|
2015-06-09 |
2018-06-07 |
Regents Of The University Of Minnesota |
Methods for detecting risk of having a bloodstream infection and compositions for reducing the risk
|
|
PL3240554T3
(pl)
|
2015-06-15 |
2020-02-28 |
4D Pharma Research Limited |
Blautia stercosis i wexlerae do stosowania w leczeniu chorób zapalnych i autoimmunologicznych
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
JP6426264B2
(ja)
|
2015-06-15 |
2018-11-21 |
フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ |
細菌株を含む組成物
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
RS59038B1
(sr)
|
2015-06-15 |
2019-08-30 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
|
JP2018519295A
(ja)
|
2015-06-22 |
2018-07-19 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
粘膜固有層調節性ｔ細胞の誘導
|
|
KR20180025908A
(ko)
|
2015-07-08 |
2018-03-09 |
세레스 테라퓨틱스, 인코포레이티드 |
대장염의 치료 방법
|
|
JP7088827B2
(ja)
|
2015-08-24 |
2022-06-21 |
ニューバイヨタ エルエルシー |
糞便由来細菌集団を使用する腸内毒素症の治療システム及び方法
|
|
CA3003138A1
(en)
|
2015-10-26 |
2017-05-04 |
Crestovo Holdings Llc |
Compositions and methods for fecal microbiota-related therapy
|
|
CA3005781C
(en)
|
2015-11-20 |
2019-01-22 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
MX2018006283A
(es)
|
2015-11-24 |
2019-09-06 |
Seres Therapeutics Inc |
Composiciones bacterianas diseñadas.
|
|
HK1246670B
(en)
|
2016-03-04 |
2020-05-15 |
4D Pharma Plc |
Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
|
|
US20170290889A1
(en)
|
2016-04-11 |
2017-10-12 |
New York University |
Methods and compositions for treating dysbiosis and gastrointestinal and inflammatory disorders
|
|
KR102554351B1
(ko)
*
|
2016-06-14 |
2023-07-13 |
베단타 바이오사이언시즈, 인크. |
클로스트리디움 디피실레 감염의 치료
|
|
US9999641B2
(en)
*
|
2016-06-14 |
2018-06-19 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
|
JP7516007B2
(ja)
*
|
2016-06-28 |
2024-07-16 |
セリバ・バイオロジクス・インコーポレイテッド |
経口抗生物質からのマイクロバイオーム防御
|
|
WO2018080477A1
(en)
*
|
2016-10-26 |
2018-05-03 |
The Joan & Irwin Jacobs Technion-Cornell Institute |
Systems and methods for ultra-fast identification and abundance estimates of microorganisms using a kmer-depth based approach and privacy-preserving protocols
|
|
US20210196766A1
(en)
|
2018-05-24 |
2021-07-01 |
Seres Therapeutics, Inc. |
Designed bacterial compositions and uses thereof
|
|
IL280779B2
(en)
*
|
2018-08-17 |
2025-05-01 |
Vedanta Biosciences Inc |
Compositions for use in the treatment or prevention of Clostridium difficile infection
|
|
CN117241809A
(zh)
|
2021-01-21 |
2023-12-15 |
韦丹塔生物科学股份有限公司 |
用于治疗肝性脑病的组合物和方法
|